For some moms, its barely noticeable, while for others, it can be more pronounced and may even cause discomfort or skin irritation
October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
Multiple follow-up studies confirmed the ability of MT-II to improve erections in men with erectile dysfunction, including in men with organic ED (caused by physical, rather than psychological problems) [8, 19]
These taxa contribute to butyrate and propionate production, metabolites that have been implicated in modulating endogenous GLP-1 secretion, intestinal barrier integrity, and inflammatory tone
However, policies can vary between organizations and may be updated as new safety data emerges